Rethinking EDC: Why AI Demands a New Foundation for Clinical Data Management
At Veeva R&D and Quality Summit 2025, we spoke with Manny Vazquez, Senior Director of Clinical Data Strategy at...
Redefining Clinical Imaging: How a Site-First Approach is Setting a New Standard for Transparency and Data Integrity
At DPHARM, we spoke with Patrick McNamara, Chief Commercial Officer at Yunu, about how the company is transforming imaging...
Building Trust Through Transparency: Apellis Pharma’s Steph Viscomi on Lean TMF and Site Collaboration
At the Veeva R&D and Quality Summit, we spoke with Steph Viscomi, Head of TMF at Apellis Pharma, about...
ProofPilot and Lokavant Aquisition: Aligning Trial Ops with Predictive Analytics
In this interview, we sit down with Chris Venezia, CEO, and Joseph Kim, Chief Strategy Officer at ProofPilot, to...
Using Behavioral AI to Predict and Prevent Clinical Trial Dropouts
At SCOPE Europe 2025, we spoke with Dominique Demolle, CEO of Cognivia, about how behavioral AI is helping sponsors...
Exosome Exotherapy: Lior Shaltiel on a Platform for CNS Regeneration
Today, we sit down with Dr. Lior Shaltiel of NurExone Biologics to explore how exosome-based delivery of siRNA could...
First Pharma to Restore Sense of Smell? Inside the FLAVOR Trial Quest to Treat Postviral Olfactory Loss
In this interview, I’m talking with Rick Geoffrion, Founder, President, and CEO of Cyrano Therapeutics, about FLAVOR, a Phase...
Shining Light on Women’s Health: A New Non-Drug Vaginal Therapy
In this interview, I spoke with Dr. Melanie Santos, Chief Medical Officer at Cern Corporation, about a novel low...
The Human Cost of Fragmented Technology: A Conversation with Veeva’s Bree Burks
At the Veeva R&D and Quality Summit in Boston, we spoke with Bree Burks, Vice President of Strategy at...
Dye-Driven Precision: Targeting Chemo Directly to Tumors
Lyle Small leads a biotech startup pursuing a bold new approach: dye-drug conjugates that carry chemotherapy directly to cancer...